Primary Ciliary Dyskinesia (PCD)/Immotile Cilia Syndrome Panel
Summary and Pricing
Test Method
Exome Sequencing with CNV DetectionTest Code | Test Copy Genes | Panel CPT Code | Gene CPT Codes Copy CPT Code | Base Price | |
---|---|---|---|---|---|
10411 | Genes x (50) | 81479 | 81479(x100) | $990 | Order Options and Pricing |
Pricing Comments
We are happy to accommodate requests for testing single genes in this panel or a subset of these genes. The price will remain the list price. If desired, free reflex testing to remaining genes on panel is available. Alternatively, a single gene or subset of genes can also be ordered via our Custom Panel tool.
An additional 25% charge will be applied to STAT orders. STAT orders are prioritized throughout the testing process.
Click here for costs to reflex to whole PGxome (if original test is on PGxome Sequencing platform).
Click here for costs to reflex to whole PGnome (if original test is on PGnome Sequencing platform).
Turnaround Time
3 weeks on average for standard orders or 2 weeks on average for STAT orders.
Please note: Once the testing process begins, an Estimated Report Date (ERD) range will be displayed in the portal. This is the most accurate prediction of when your report will be complete and may differ from the average TAT published on our website. About 85% of our tests will be reported within or before the ERD range. We will notify you of significant delays or holds which will impact the ERD. Learn more about turnaround times here.
Targeted Testing
For ordering sequencing of targeted known variants, go to our Targeted Variants page.
Clinical Features and Genetics
Clinical Features
Primary ciliary dyskinesia (PCD) is a genetic disorder affecting the function of motile cilia with an incidence of 1 in 16,000 individuals (Leigh et al. 2009. PubMed ID: 19606528). The hallmark features of PCD are neonatal respiratory distress, chronic coughing, and recurrent sinus or ear infections; 80-100% of all PCD patients have one or more of these symptoms. In 20-50% of individuals with PCD, the major visceral organs are reversed from their normal positions (also called situs inversus; Sutherland and Ware. 2009. PubMed ID: 19876930). Kartagener’s syndrome is a similar condition defined by the symptomatic triad of situs inversus, sinusitis and bronchiectasis. Patients with PCD can also have abnormal orientation of some organs, but not others (a condition called situs ambiguous or heterotaxy; Kennedy et al. 2007. PubMed ID: 17515466). For more information, see GeneReviews (Zariwala et al. 2019. PubMed ID: 20301301).
The majority of PCD patients have neonatal symptoms and around half have situs inversus but, despite these signs, diagnosis is often delayed (Collins et al. 2014. PubMed ID: 26237387). This prevents early use of regular airway clearance therapy, aggressive management of infections, monitoring and treatment of hearing impairment and genetic counselling for the family. Genetic testing is helpful in identifying patients that need functional assessment and improving the diagnostic process.
Genetics
To date, defects in over 50 genes have been reported to cause PCD, which is mostly inherited in an autosomal recessive manner (Zariwala et al. 2019. PubMed ID: 20301301). In rare cases, PCD has been found to be inherited in X-linked or autosomal dominant manners due to loss-of-function variants in OFD1, RPGR, DNAAF6/PIH1D3, and FOXJ1 (Budny et al. 2006. PubMed ID: 16783569; Moore et al 2006. PubMed ID: 16055928; Olcese et al. 2017. PubMed ID: 28176794; Wallmeier. 2019. PubMed ID: 31630787). De novo variants have been reported in the FOXJ1 gene (Wallmeier. 2019. PubMed ID: 31630787). Copy number variants have been documented in the ODAD2/ARMC4, CCDC40, DNAAF1, DNAAF2, DNAH11, DNAH5, DNAAF4 SPAG1, OFD1, DNAAF6, RPGR, and ZMYND10 genes (Human Gene Mutation Database). In addition, the INVS/NPHP2 gene has been associated with situs inversus either with or without biliary complications (Schön et al. 2002. PubMed ID: 11935322; Otto et al. 2003. PubMed ID: 12872123).
PCD is caused by defects in motile cilia. Cilia in the respiratory tract, brain, and sperm flagella consist of nine peripheral microtubule doublets surrounding two central microtubules; nodal cilia in the embryo lack the central microtubules (Ferkol and Leigh. 2006. PubMed ID: 17142159). All motile cilia have both inner and outer dynein arms attached at regular intervals to the peripheral microtubule doublets. The dynein arms consist of heavy, intermediate, and light dynein chains and serve as molecular motors that drive microtubule sliding. Most frequently, patients with PCD have structural defects in the outer dynein arms, rendering the cilia immotile and non-functional.
See individual gene summaries for information about molecular biology of gene products and spectra of pathogenic variants.
Clinical Sensitivity - Sequencing with CNV PGxome
Clinical sensitivity is ~80% (Zariwala et al. 2019. PubMed ID: 20301301).
Testing Strategy
This test is performed using Next-Gen sequencing with additional Sanger sequencing as necessary.
This panel typically provides 91.0% coverage of all coding exons of the genes plus 10 bases of flanking noncoding DNA in all available transcripts along with other non-coding regions in which pathogenic variants have been identified at PreventionGenetics or reported elsewhere. We define coverage as ≥20X NGS reads or Sanger sequencing. PGnome panels typically provide slightly increased coverage over the PGxome equivalent. PGnome sequencing panels have the added benefit of additional analysis and reporting of deep intronic regions (where applicable).
Due to technical difficulties, only exons 1-5 and 85-86 of the HYDIN gene are included in this panel.
Dependent on the sequencing backbone selected for this testing, discounted reflex testing to any other similar backbone-based test is available (i.e., PGxome panel to whole PGxome; PGnome panel to whole PGnome).
Indications for Test
This test is for patients with symptoms of respiratory distress (chronic coughing, recurrent sinusitis, bronchiectasis), with or without situs inversus. For patients with laterality defects (Heterotaxy, Situs Inversus, Situs ambiguous) but no overt symptoms of respiratory distress, see the Heterotaxy, Situs Inverus and Kartagener's Syndrome Panel.
This test is for patients with symptoms of respiratory distress (chronic coughing, recurrent sinusitis, bronchiectasis), with or without situs inversus. For patients with laterality defects (Heterotaxy, Situs Inversus, Situs ambiguous) but no overt symptoms of respiratory distress, see the Heterotaxy, Situs Inverus and Kartagener's Syndrome Panel.
Genes
Inheritance | Abbreviation |
---|---|
Autosomal Dominant | AD |
Autosomal Recessive | AR |
X-Linked | XL |
Mitochondrial | MT |
Diseases
Related Test
Name |
---|
PGxome® |
Male Infertility Panel |
Citations
- Budny et al. 2006. PubMed ID: 16783569
- Collins et al. 2014. PubMed ID: 26237387
- Ferkol and Leigh 2006. PubMed ID: 17142159
- Human Gene Mutation Database (Bio-base).
- Kennedy. et al. 2007. PubMed ID: 17515466
- Leigh et al. 2009. PubMed ID: 19606528
- Moore et al. 2006. PubMed ID: 16055928
- Olcese et al. 2017. PubMed ID: 28176794
- Otto et al. 2003. PubMed ID: 12872123
- Schön et al. 2002. PubMed ID: 11935322
- Sutherland and Ware. 2009. PubMed ID: 19876930
- Wallmeier et al. 2019. PubMed ID: 31630787
- Zariwala et al. 2019. PubMed ID: 20301301
Ordering/Specimens
Ordering Options
We offer several options when ordering sequencing tests. For more information on these options, see our Ordering Instructions page. To view available options, click on the Order Options button within the test description.
myPrevent - Online Ordering
- The test can be added to your online orders in the Summary and Pricing section.
- Once the test has been added log in to myPrevent to fill out an online requisition form.
- PGnome sequencing panels can be ordered via the myPrevent portal only at this time.
Requisition Form
- A completed requisition form must accompany all specimens.
- Billing information along with specimen and shipping instructions are within the requisition form.
- All testing must be ordered by a qualified healthcare provider.
For Requisition Forms, visit our Forms page
If ordering a Duo or Trio test, the proband and all comparator samples are required to initiate testing. If we do not receive all required samples for the test ordered within 21 days, we will convert the order to the most effective testing strategy with the samples available. Prior authorization and/or billing in place may be impacted by a change in test code.
Specimen Types
Specimen Requirements and Shipping Details
PGxome (Exome) Sequencing Panel
PGnome (Genome) Sequencing Panel
ORDER OPTIONS
View Ordering Instructions1) Select Test Type
2) Select Additional Test Options
No Additional Test Options are available for this test.